Review
Psychiatry
Aline J. Waclawovsky, Edineia de Brito, Lee Smith, Davy Vancampfort, Antonio M. da Silva, Felipe B. Schuch
Summary: Individuals diagnosed with depression show impaired endothelial dysfunction compared to controls, with HDL cholesterol levels and differences in FMD assessment modalities moderating the difference. The study suggests that clinical depression may lead to greater dysfunction in endothelial function.
JOURNAL OF PSYCHIATRIC RESEARCH
(2021)
Review
Psychiatry
Yufei Wu, Danni Yan, Jianli Yang
Summary: This study aimed to explore further the efficacy of yoga for patients with MDD. Analysis of 34 RCT studies showed that yoga had a moderate effect on improving depressive symptoms and severity, but had a negligible effect on anxiety levels. No adverse events occurred in the yoga group during treatment.
FRONTIERS IN PSYCHIATRY
(2023)
Review
Clinical Neurology
Edoardo G. Ostinelli, Caroline Zangani, Barbara Giordano, Davide Maestri, Orsola Gambini, Armando D'Agostino, Toshi A. Furukawa, Marianna Purgato
Summary: This study synthesized evidence from 92 studies and found that the prevalence of depression in individuals with Internet Gaming Disorder (IGD) varied considerably across studies, affecting approximately one out of three participants overall. Furthermore, globally major severity of depressive symptoms was found in IGD participants without a clinical diagnosis of depression.
JOURNAL OF AFFECTIVE DISORDERS
(2021)
Review
Sport Sciences
Jacinta Brinsley, Felipe Schuch, Oscar Lederman, Danielle Girard, Matthew Smout, Maarten A. Immink, Brendon Stubbs, Joseph Firth, Kade Davison, Simon Rosenbaum
Summary: This study reviewed 19 studies and conducted meta-analysis to assess the effectiveness of physically active yoga in alleviating depressive symptoms. The results showed that physically active yoga was superior to waitlist control, treatment as usual, and attention control in reducing depressive symptoms.
BRITISH JOURNAL OF SPORTS MEDICINE
(2021)
Review
Clinical Neurology
Kwonmok Ko, Emma I. Kopra, Anthony J. Cleare, James J. Rucker
Summary: Psychedelic therapy shows promising therapeutic effects on depressive symptoms according to recent clinical research. Psilocybin, ayahuasca, and LSD demonstrated significant reduction of symptoms in both short-term and long-term treatment.
JOURNAL OF AFFECTIVE DISORDERS
(2023)
Review
Biochemistry & Molecular Biology
Mubashir Hassan, Aqsa Amir, Saba Shahzadi, Andrzej Kloczkowski
Summary: MicroRNAs play a significant role in depression, affecting associated proteins and signaling pathways. They have the potential to be used as biomarkers and therapy targets for treating depression.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
(2022)
Review
Oncology
Daniel C. McFarland, Meredith Doherty, Thomas M. Atkinson, Robin O'Hanlon, William Breitbart, Christian J. Nelson, Andrew H. Miller
Summary: This study conducted a systematic review and meta-analysis to examine the relationship between inflammation and depression in cancer patients. The findings suggest that peripheral inflammatory markers, such as IL-6, TNF, and CRP, are associated with depressive symptoms in various cancer settings. These results have implications for the identification and management of depression in cancer patients.
Review
Clinical Neurology
Riccardo De Giorgi, Shona Waters, Nicola Rizzo Pesci, Gianluca Rosso, Philip J. Cowen, Catherine J. Harmer
Summary: This meta-analysis study found that statin monotherapy does not improve depressive symptoms, but may be useful for managing depression in addition to antidepressants.
JOURNAL OF AFFECTIVE DISORDERS
(2022)
Review
Clinical Neurology
Kody G. Kennedy, Megan Mio, Benjamin I. Goldstein, Paolo Brambilla, Giuseppe Delvecchio
Summary: This review and meta-analysis found that individuals with severe mental illness, especially schizophrenia, have wider retinal venules compared to controls, indicating a potential connection between cerebrovascular health and mental illness.
JOURNAL OF AFFECTIVE DISORDERS
(2023)
Review
Orthopedics
Ahmed Khalil Attia, Greg A. J. Robertson, John McKinley, Pieter P. d'Hooghe, Nicola Maffulli
Summary: This study aimed to determine the effect of orthobiologic augmentation on the outcome of surgically managed Jones fractures in athletes. The findings suggest that biologically augmented fixation can increase the fracture union rate, but has similar rates of return to play and time to return to play compared to fixation alone.
AMERICAN JOURNAL OF SPORTS MEDICINE
(2023)
Review
Biochemistry & Molecular Biology
Qiong Yu, Fengyu Xue, Zhijun Li, Xinwei Li, Lizhe Ai, Mengdi Jin, Mengtong Xie, Yaqin Yu
Summary: Through a meta-analysis of multiple studies, it was found that the intake of total carotenoids, beta-carotene, alpha-carotene, lycopene, and/or corn xanthin was significantly inversely associated with depressive symptoms, while beta-cryptoxanthin showed no significant correlation. The results suggest that carotenoids may act as protective factors for depressive symptoms, and dietary intake may help reduce the risk of depressive symptoms.
Review
Clinical Neurology
Gianfranco W. Basualdo-Melendez, Akram Hernandez-Vasquez, Francisco A. Baron-Lozada, Rodrigo Vargas-Fernandez
Summary: This study aimed to determine the prevalence of depression or depressive symptoms in people residing in high-altitude regions. A systematic review and meta-analysis of 8 articles with over 40,000 participants from 4 countries showed that the combined prevalence of depressive symptoms was 17.9%, with China having a prevalence rate of 28.7%. The findings emphasize the need for interventions and further research on depressive symptoms in high-altitude regions.
JOURNAL OF AFFECTIVE DISORDERS
(2022)
Review
Ergonomics
Sohrab Amiri
Summary: This study found a clear association between unemployment and depressive symptoms and major depressive disorder, with higher prevalence among the unemployed, indicating negative impacts on their mental health.
INTERNATIONAL JOURNAL OF OCCUPATIONAL SAFETY AND ERGONOMICS
(2022)
Review
Psychiatry
Damien Etchecopar-Etchart, Theo Korchia, Anderson Loundou, Pierre-Michel Llorca, Pascal Auquier, Christophe Lancon, Laurent Boyer, Guillaume Fond
Summary: This study found a high prevalence of comorbid major depressive disorder in schizophrenia patients, with factors like publication year, study size, assessment tools, comorbid conditions, demographics, hospitalizations, and antidepressant use influencing the prevalence rate. Further research is needed to explore other potential factors contributing to the high prevalence of SZ-MDD.
SCHIZOPHRENIA BULLETIN
(2021)
Review
Psychology, Clinical
Sukanta Saha, Carmen C. W. Lim, Danielle L. Cannon, Lucinda Burton, Monique Bremner, Peter Cosgrove, Yan Huo, John J. McGrath
Summary: This study conducted a meta-analysis to explore the comorbidity between mood and anxiety disorders, finding consistent evidence of a substantial association regardless of diagnostic criteria, study timeframe, or adjustments. Clinicians should be aware of the high prevalence of this common comorbidity and ensure prompt identification and treatment.
DEPRESSION AND ANXIETY
(2021)